Treatment of brain metastases and cns metastases using illudins or hydroxylureamethyl acylfulvene
US-2024325328-A1 · Oct 3, 2024 · US
US10598667B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10598667-B2 |
| Application number | US-201414780484-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 26, 2014 |
| Priority date | Mar 26, 2013 |
| Publication date | Mar 24, 2020 |
| Grant date | Mar 24, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides kits and methods for detecting peptides that change of the fluorescence of dyes upon binding to the dye. In addition, the invention provides methods for identifying said peptides.
Opening claim text (preview).
What is claimed is: 1. A method of detecting a peptide, comprising: contacting the peptide with an organic dye and a chelating metal ion, such that the peptide specifically binds to the dye changing the fluorescence properties of the dye, wherein the peptide is 12 to 100 amino acids in length and is conformationally constrained by the chelating metal ion, and wherein the organic dye is selected from the group consisting of triarylmethane dyes, benzylidene imidazolinone dyes, and variants thereof; and detecting the change in fluorescence properties of the dye, thereby detecting the peptide, wherein the peptide comprises the formula: (IIb) (SEQ ID NO: 186) DX 2 X 3 X 4 X 5 GX 7 X 8 X 9 X 10 X 11 E, wherein: each of X 2 , X 3 , X 4 , and X 5 is an amino acid independently selected from the group consisting of D, A, Y, and W, wherein at least one of X 2 , X 3 , X 4 , and X 5 is D and at least one of X 2 , X 3 , X 4 , and X 5 is W; and each of X 7 , X 8 , X 9 , X 10 , and X 11 is an amino acid independently selected from the group consisting of V, L, I, M, F, N, E, Q, H, K, R, D, G, A, S, T, Y, W, C and P. 2. The method of claim 1 , wherein the peptide is 12 to 50 amino acids in length. 3. The method of claim 1 , wherein the peptide is a linear peptide. 4. The method of claim 1 , wherein the peptide is a peptide cyclized by a disulfide bond. 5. The method of claim 1 , wherein the chelating metal ion is Ca 2+ or Zn 2+ . 6. The method of claim 1 , wherein the peptide has at least one post-translational modification. 7. The method of claim 1 , wherein the peptide is further fused to a protein. 8. The method of claim 7 , wherein the protein comprises a targeting moiety. 9. The method of claim 8 , wherein the targeting moiety comprises an antibody, antibody fragment, peptide aptamer or variant thereof. 10. The method of claim 8 , wherein the targeting moiety comprises a viral protein. 11. The method of claim 8 , wherein the targeting moiety comprises an ion channel or a membrane receptor. 12. The method of claim 1 , wherein the peptide is selected from the group consisting of: (SEQ ID NO: 204) DAYWDGTGHIYE, (SEQ ID NO: 31) DWWDWGNHGYTE, and (SEQ ID NO: 23) DWWWDGFERLEE.
General methods of protein analysis not limited to specific proteins or families of proteins · CPC title
containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title
with fluorescent label · CPC title
containing a motif for post-translational modification · CPC title
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.